ROIX — Response Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Response Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R1997 December 31st	1998 December 31st	1999 December 31st	2000 December 31st	2001 December 31st
Period Length:	—	—	—	—	—
Source:	10-K405	10-K405	10-K405	10-K405	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.42	1.08	7.2	7.33	7.91
Net Total Accounts Receivable
Net Total Receivables	16.9	22.8	16	9.47	5.92
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41.1	52.2	48.5	44.3	28.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.56	5.27	4.22	3.21	0.614
Net Intangible Assets
Other Long Term Assets
Total Assets	149	127	120	92.4	28.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.7	35.8	25.1	54	2.31
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	82.7	77.3	71.9	59	46.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	66.3	49.4	47.8	33.4	-18
Total Liabilities & Shareholders' Equity	149	127	120	92.4	28.9
Total Common Shares Outstanding
Total Preferred Shares Outstanding